Company registration number 06906017 (England and Wales)
CARE IN MIND LIMITED
ANNUAL REPORT AND CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
CARE IN MIND LIMITED
COMPANY INFORMATION
Directors
Dr D M Kingsley
Dr R E O'Driscoll
(Appointed 10 July 2025)
Mr D J Power
(Appointed 10 July 2025)
Mr A M Knight
(Appointed 10 July 2025)
Company number
06906017
Registered office
Hope House
Unit B2 Hercules Office Park
Bird Hall Lane
Stockport
Cheshire
SK3 0UX
Auditor
Xeinadin Audit Limited
First Floor, The Foundation
Herons Way
Chester Business Park
Chester
Cheshire
CH4 9GB
CARE IN MIND LIMITED
CONTENTS
Page
Strategic report
1 - 2
Directors' report
3 - 4
Independent auditor's report
5 - 7
Profit and loss account
8
Group statement of comprehensive income
9
Group balance sheet
10
Company balance sheet
11
Group statement of changes in equity
12
Company statement of changes in equity
13
Group statement of cash flows
14
Notes to the financial statements
15 - 30
CARE IN MIND LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 MARCH 2025
- 1 -
The directors present the strategic report for the year ended 31 March 2025.
Review of the business
Since 2012, Care in Mind has offered specialist mental health packages to young people aged 16-30 in residential care settings. Our innovative and evidence-based model of care aims to support young people presenting with high levels of complexity and risk in the least restrictive setting.
Many of the young people we work with transition to us from inpatient settings and may have experienced numerous previous admissions and/or placement breakdowns. Our unique model provides 24/7 on-call and crisis intervention support, which helps us support our young people in maintaining their community placement and avoiding readmission. The company operates out of 10 residential locations and Head Office in Stockport.
The Directors are satisfied with the year's Group results given the difficult trading environment experienced in the UK during the period coupled with further increases in costs most notably the UK minimum wage. Group turnover was £10,731,371 (2024: £10,411,970) with a gross profit of £2,739,379 (2024: £2,983,945). The gross margin was 25.5% compared to 28.7% in the prior year. The net profit before tax was £574,289 (2024: £984,970). The commercial environment has been challenging with regards to the Real Living Wage increase in addition to NI contributions. In light of this we have made considerable improved cost efficiencies without compromising on the quality of care provided and outcomes achieved.
We are pleased to report that all of our homes are consistently achieving good or outstanding ratings with the CQC.
Principal risks and uncertainties
Principal Risks are staff recruitment, generation of referrals into our care and ensuring the safeguarding of young people in our care. The economic climate and stretched local authority and Integrated Care Board funding is always a challenge but the business demonstrates its proficiency by outstanding outcomes.
The business employs first class management systems and staff which ensures the integrity of service and proficiency in collecting customer remittances to mitigate any risk of poor financial control. The company has secured quality funding from HSBC which ensures any shortfalls in customer remittances are covered.
Key controls are:
Excellence in providing service user care
Compliance with CQC governance
Quality Staff recruitment and appropriate staffing levels incorporating Disclosure and Barring Service (DBS) checks
Daily cash management
Timely financial reporting
Detailed Budgets and forecasts
Key performance indicators
The primary business KPI is occupancy rates, being the % of total rooms occupied. Occupancy rates at each home are monitored by the Directors and are used to manage the income and cash flow.
The Directors also use secondary related KPIs to monitor business performance such as CQC ratings and EBITDA.
Other information and explanations
Care in Mind Holdings Limited are the new ultimate holding company for Care in Mind Limited and Santiago Holdings Limited from October 2025.
CARE IN MIND LIMITED
STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 2 -
Dr D M Kingsley
Director
18 December 2025
CARE IN MIND LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 MARCH 2025
- 3 -
The directors present their annual report and financial statements for the year ended 31 March 2025.
Principal activities
The principal activity of the company and group continued to be that of mental health and care facilities.
Results and dividends
The results for the year are set out on page 8.
Ordinary dividends were paid amounting to £334,494. The directors do not recommend payment of a further dividend.
Directors
The directors who held office during the year and up to the date of signature of the financial statements were as follows:
Dr D M Kingsley
Dr R E O'Driscoll
(Appointed 10 July 2025)
Mr D J Power
(Appointed 10 July 2025)
Mr A M Knight
(Appointed 10 July 2025)
Disabled persons
Applications for employment by disabled persons are always fully considered, bearing in mind the aptitudes of the applicant concerned. In the event of members of staff becoming disabled, every effort is made to ensure that their employment within the group continues and that the appropriate training is arranged. It is the policy of the group that the training, career development and promotion of disabled persons should, as far as possible, be identical to that of other employees.
Employee involvement
The group's policy is to consult and discuss with employees, through unions, staff councils and at meetings, matters likely to affect employees' interests.
Information about matters of concern to employees is given through information bulletins and reports which seek to achieve a common awareness on the part of all employees of the financial and economic factors affecting the group's performance.
There is no employee share scheme at present, but the directors are considering the introduction of such a scheme as a means of further encouraging the involvement of employees in the company's performance.
CARE IN MIND LIMITED
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 4 -
Statement of directors' responsibilities
The directors are responsible for preparing the Annual Report and the financial statements in accordance with applicable law and regulations.
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the group and company, and of the profit or loss of the group for that period. In preparing these financial statements, the directors are required to:
select suitable accounting policies and then apply them consistently;
make judgements and accounting estimates that are reasonable and prudent;
state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements;
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the group and company will continue in business.
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the group’s and company’s transactions and disclose with reasonable accuracy at any time the financial position of the group and company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the group and company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
Statement of disclosure to auditor
So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the auditor of the company is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the auditor of the company is aware of that information.
Medium-sized companies exemption
This report has been prepared in accordance with the provisions applicable to companies entitled to the medium-sized companies exemption.
On behalf of the board
Dr D M Kingsley
Director
18 December 2025
CARE IN MIND LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF CARE IN MIND LIMITED
- 5 -
Opinion
We have audited the financial statements of Care In Mind Limited (the 'parent company') and its subsidiaries (the 'group') for the year ended 31 March 2025 which comprise the group profit and loss account, the group statement of comprehensive income, the group balance sheet, the company balance sheet, the group statement of changes in equity, the company statement of changes in equity, the group statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).
In our opinion the financial statements:
give a true and fair view of the state of the group's and the parent company's affairs as at 31 March 2025 and of the group's profit for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the group and parent company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of our audit:
The information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
The strategic report and the directors' report have been prepared in accordance with applicable legal requirements.
CARE IN MIND LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF CARE IN MIND LIMITED
- 6 -
Matters on which we are required to report by exception
In the light of the knowledge and understanding of the group and the parent company and their environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.
We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:
adequate accounting records have not been kept by the parent company, or returns adequate for our audit have not been received from branches not visited by us; or
the parent company financial statements are not in agreement with the accounting records and returns; or
certain disclosures of directors' remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit.
Responsibilities of directors
As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the parent company or to cease operations, or have no realistic alternative but to do so.
Auditor's responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:
Enquiry of management and those charged with governance around actual and potential litigation and claims;
Reviewing minutes of meetings of those charged with governance;
Performing audit work over the risk of management override of controls, including testing of journal entries and other adjustments for appropriateness, evaluating the business rationale of significant transactions outside the normal course of business and reviewing accounting estimates for bias;
Enquiry of management and those charged with governance to identify any instances of non-compliance with laws and regulations.
The potential effect of these laws and regulations on the financial statements varies considerably.
Firstly, the company is subject to laws and regulations that directly affect the financial statements including financial reporting legislation (including related companies legislation), distributable profits legislation and taxation legislation and we assessed the extent of compliance with these laws and regulations as part of our procedures on the related financial statement items.
Secondly, the company is subject to many other laws and regulations where the consequence of non-compliance could have a material effect on amounts or disclosures in the financial statements, for instance the imposition of fines or litigation or the loss of companies license to operate. Auditing standards limit the required audit procedures to identify non-compliance with these laws and regulations to enquiry of the members and other management and inspection of regulatory and legal correspondence, if any. Therefore, if a breach of operational regulations is not disclosed to us or evident from relevant correspondence, an audit will not detect that breach.
CARE IN MIND LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF CARE IN MIND LIMITED
- 7 -
Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.
A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.
Other matters which we are required to address
In the prior year, the company was entitled to exemption from audit under section 477 of the Companies Act 2006. The comparative figures for the year ended 31 March 2024 are therefore unaudited.
This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a body, for our audit work, for this report, or for the opinions we have formed.
Stephanie Baker BA(Hons) ACA (Senior Statutory Auditor)
For and on behalf of Xeinadin Audit Limited, Statutory Auditor
Chartered Accountants
First Floor, The Foundation
Herons Way
Chester Business Park
Chester
Cheshire
CH4 9GB
18 December 2025
CARE IN MIND LIMITED
GROUP PROFIT AND LOSS ACCOUNT
FOR THE YEAR ENDED 31 MARCH 2025
- 8 -
2025
2024
Notes
£
£
Turnover
2
10,731,371
10,411,970
Cost of sales
(7,991,992)
(7,428,025)
Gross profit
2,739,379
2,983,945
Administrative expenses
(2,184,820)
(1,999,195)
Other operating income
19,731
220
Operating profit
3
574,290
984,970
Interest receivable and similar income
5
4,878
10,353
Interest payable and similar expenses
6
(34,848)
(34,738)
Profit before taxation
544,320
960,585
Tax on profit
7
(148,630)
(247,185)
Profit for the financial year
22
395,690
713,400
Profit for the financial year is all attributable to the owner of the parent company.
CARE IN MIND LIMITED
GROUP STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 MARCH 2025
- 9 -
2025
2024
£
£
Profit for the year
395,690
713,400
Other comprehensive income
-
-
Total comprehensive income for the year
395,690
713,400
Total comprehensive income for the year is all attributable to the owner of the parent company.
CARE IN MIND LIMITED
GROUP BALANCE SHEET
AS AT
31 MARCH 2025
31 March 2025
- 10 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
Tangible assets
9
202,882
287,322
202,882
287,322
Current assets
Debtors
13
2,895,249
2,582,740
Cash at bank and in hand
262,912
540,559
3,158,161
3,123,299
Creditors: amounts falling due within one year
14
(1,106,960)
(1,119,938)
Net current assets
2,051,201
2,003,361
Total assets less current liabilities
2,254,083
2,290,683
Creditors: amounts falling due after more than one year
15
(111,825)
(205,463)
Provisions for liabilities
Deferred tax liability
18
4,158
-
(4,158)
Net assets
2,142,258
2,081,062
Capital and reserves
Called up share capital
20
200
200
Other reserves
595,428
595,428
Profit and loss reserves
22
1,546,630
1,485,434
Total equity
2,142,258
2,081,062
These financial statements have been prepared in accordance with the provisions relating to medium-sized groups.
The financial statements were approved by the board of directors and authorised for issue on 18 December 2025 and are signed on its behalf by:
18 December 2025
Dr D M Kingsley
Director
Company registration number 06906017 (England and Wales)
CARE IN MIND LIMITED
COMPANY BALANCE SHEET
AS AT 31 MARCH 2025
31 March 2025
- 11 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
9
12,170
18,216
Investments
10
3
3
12,173
18,219
Current assets
Debtors
13
1,078,500
951,710
Cash at bank and in hand
34,337
44,603
1,112,837
996,313
Creditors: amounts falling due within one year
14
(413,524)
(206,447)
Net current assets
699,313
789,866
Total assets less current liabilities
711,486
808,085
Provisions for liabilities
Deferred tax liability
18
3,042
4,554
(3,042)
(4,554)
Net assets
708,444
803,531
Capital and reserves
Called up share capital
20
200
200
Profit and loss reserves
22
708,244
803,331
Total equity
708,444
803,531
As permitted by s408 Companies Act 2006, the company has not presented its own profit and loss account and related notes. The company’s profit for the year was £239,407 (2024 - £354,332 profit).
These financial statements have been prepared in accordance with the provisions relating to medium-sized companies.
The financial statements were approved by the board of directors and authorised for issue on 18 December 2025 and are signed on its behalf by:
18 December 2025
Dr D M Kingsley
Director
Company registration number 06906017 (England and Wales)
CARE IN MIND LIMITED
GROUP STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2025
- 12 -
Share capital
Merger reserve
Profit and loss reserves
Total
Notes
£
£
£
£
Balance at 1 April 2023
200
595,428
1,113,693
1,709,321
Year ended 31 March 2024:
Profit and total comprehensive income
-
-
713,400
713,400
Dividends
8
-
-
(341,659)
(341,659)
Balance at 31 March 2024
200
595,428
1,485,434
2,081,062
Year ended 31 March 2025:
Profit and total comprehensive income
-
-
395,690
395,690
Dividends
8
-
-
(334,494)
(334,494)
Balance at 31 March 2025
200
595,428
1,546,630
2,142,258
CARE IN MIND LIMITED
COMPANY STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2025
- 13 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 1 April 2023
200
790,657
790,857
Year ended 31 March 2024:
Profit and total comprehensive income for the year
-
354,333
354,333
Dividends
8
-
(341,659)
(341,659)
Balance at 31 March 2024
200
803,331
803,531
Year ended 31 March 2025:
Profit and total comprehensive income
-
239,407
239,407
Dividends
8
-
(334,494)
(334,494)
Balance at 31 March 2025
200
708,244
708,444
CARE IN MIND LIMITED
GROUP STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 MARCH 2025
- 14 -
2025
2024
Notes
£
£
£
£
Cash flows from operating activities
Cash generated from operations
28
327,893
295,956
Interest paid
(34,848)
(34,738)
Income taxes paid
(203,852)
(210,568)
Net cash inflow from operating activities
89,193
50,650
Investing activities
Purchase of tangible fixed assets
(19,491)
(64,859)
Proceeds from disposal of tangible fixed assets
-
7,501
Repayment of loans
100,000
-
Interest received
4,878
10,353
Net cash generated from/(used in) investing activities
85,387
(47,005)
Financing activities
Repayment of bank loans
(60,605)
(9,647)
Payment of finance leases obligations
(57,128)
(19,129)
Dividends paid to equity shareholders
(334,494)
(341,659)
Net cash used in financing activities
(452,227)
(370,435)
Net decrease in cash and cash equivalents
(277,647)
(366,790)
Cash and cash equivalents at beginning of year
540,559
907,349
Cash and cash equivalents at end of year
262,912
540,559
CARE IN MIND LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
- 15 -
1
Accounting policies
Company information
Care In Mind Limited (“the company”) is a private limited company domiciled and incorporated in England and Wales. The registered office is Hope House, Unit B2 Hercules Office Park, Bird Hall Lane, Stockport, Cheshire, SK3 0UX.
The group consists of Care In Mind Limited and all of its subsidiaries.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
The company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements for parent company information presented within the consolidated financial statements:
Section 7 ‘Statement of Cash Flows’: Presentation of a statement of cash flow and related notes and disclosures;
Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instrument Issues: Interest income/expense and net gains/losses for financial instruments not measured at fair value; basis of determining fair values; details of collateral, loan defaults or breaches, details of hedges, hedging fair value changes recognised in profit or loss and in other comprehensive income;
Section 33 ‘Related Party Disclosures’: Compensation for key management personnel.
1.2
Business combinations
In the parent company financial statements, the cost of a business combination is the fair value at the acquisition date of the assets given, equity instruments issued and liabilities incurred or assumed, plus costs directly attributable to the business combination. The excess of the cost of a business combination over the fair value of the identifiable assets, liabilities and contingent liabilities acquired is recognised as goodwill. The cost of the combination includes the estimated amount of contingent consideration that is probable and can be measured reliably, and is adjusted for changes in contingent consideration after the acquisition date. Provisional fair values recognised for business combinations in previous periods are adjusted retrospectively for final fair values determined in the 12 months following the acquisition date. Investments in subsidiaries, joint ventures and associates are accounted for at cost less impairment.
Deferred tax is recognised on differences between the value of assets (other than goodwill) and liabilities recognised in a business combination accounted for using the purchase method and the amounts that can be deducted or assessed for tax, considering the manner in which the carrying amount of the asset or liability is expected to be recovered or settled. The deferred tax recognised is adjusted against goodwill or negative goodwill.
CARE IN MIND LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 16 -
1.3
Basis of consolidation
The consolidated group financial statements consist of the financial statements of the parent company Care In Mind Limited together with all entities controlled by the parent company (its subsidiaries) and the group’s share of its interests in joint ventures and associates.
All financial statements are made up to 31 March 2025. Where necessary, adjustments are made to the financial statements of subsidiaries to bring the accounting policies used into line with those used by other members of the group.
All intra-group transactions, balances and unrealised gains on transactions between group companies are eliminated on consolidation. Unrealised losses are also eliminated unless the transaction provides evidence of an impairment of the asset transferred.
The merger accounting method has been applied to group reconstructions under common control. The assets and liabilities of Care in Mind Residential Services Limited were consolidated at their carrying amounts, and no goodwill arose upon consolidation. Any difference between the consideration paid and the share of net assets acquired has been recognised in the merger reserve being £595,428.
Subsidiaries are consolidated in the group’s financial statements from the date that control commences until the date that control ceases.
1.4
Going concern
At the time of approving the financial statements, the directors have a reasonable expectation that the group has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.
1.5
Turnover
Revenue comprises sales of services provided to customers net of value added tax and other sales taxes. Revenue is recognised when performance obligations are satisfied and the control of services are transferred to the recipient. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.
1.6
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Plant and equipment
33% on cost
Fixtures and fittings
15% on cost
Computers
33% on cost
Motor vehicles
20% reducing balance
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the profit and loss account.
CARE IN MIND LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 17 -
1.7
Fixed asset investments
Equity investments are measured at fair value through profit or loss, except for those equity investments that are not publicly traded and whose fair value cannot otherwise be measured reliably, which are recognised at cost less impairment until a reliable measure of fair value becomes available.
In the parent company financial statements, investments in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses.
A subsidiary is an entity controlled by the group. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.
1.8
Impairment of fixed assets
At each reporting period end date, the group reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
The carrying amount of the investments accounted for using the equity method is tested for impairment as a single asset. Any goodwill included in the carrying amount of the investment is not tested separately for impairment.
Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.
If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.
Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.
1.9
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
CARE IN MIND LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 18 -
1.10
Financial instruments
The group has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the group's balance sheet when the group becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset and the net amounts presented in the financial statements when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Other financial assets
Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.
Impairment of financial assets
Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.
Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.
If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.
Derecognition of financial assets
Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the group transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the group after deducting all of its liabilities.
CARE IN MIND LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 19 -
Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
Other financial liabilities
Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.
Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value through profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.
Derecognition of financial liabilities
Financial liabilities are derecognised when the group's contractual obligations expire or are discharged or cancelled.
1.11
Equity instruments
Equity instruments issued by the group are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the group.
1.12
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The group’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
CARE IN MIND LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 20 -
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset if, and only if, there is a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
1.13
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
1.14
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
1.15
Leases
Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.
Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.
Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leased asset are consumed.
2
Turnover and other revenue
2025
2024
£
£
Turnover analysed by class of business
Mental health support
10,731,371
10,411,970
CARE IN MIND LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
2
Turnover and other revenue
(Continued)
- 21 -
2025
2024
£
£
Turnover analysed by geographical market
United Kingdom
10,731,371
10,411,970
2025
2024
£
£
Other revenue
Interest income
4,878
10,353
3
Operating profit
2025
2024
£
£
Operating profit for the year is stated after charging:
Fees payable to the group's auditor for the audit of the group's financial statements
17,000
-
Depreciation of owned tangible fixed assets
95,339
120,582
Loss on disposal of tangible fixed assets
8,592
8,389
Operating lease charges
12,124
12,077
4
Employees
The average monthly number of persons (including directors) employed by the group and company during the year was:
Group
Company
2025
2024
2025
2024
Number
Number
Number
Number
All employees
263
249
60
58
Their aggregate remuneration comprised:
Group
Company
2025
2024
2025
2024
£
£
£
£
Wages and salaries
6,694,455
6,165,871
2,512,228
2,358,828
Social security costs
631,577
544,255
273,768
254,090
Pension costs
322,195
252,055
186,477
135,130
7,648,227
6,962,181
2,972,473
2,748,048
CARE IN MIND LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 22 -
5
Interest receivable and similar income
2025
2024
£
£
Interest income
Interest on bank deposits
4,878
10,271
Other interest income
-
82
Total income
4,878
10,353
6
Interest payable and similar expenses
2025
2024
£
£
Interest on bank overdrafts and loans
20,235
25,368
Interest on finance leases and hire purchase contracts
4,770
8,809
Other interest
9,843
561
Total finance costs
34,848
34,738
7
Taxation
2025
2024
£
£
Current tax
UK corporation tax on profits for the current period
164,241
260,527
Deferred tax
Origination and reversal of timing differences
(15,611)
(13,342)
Total tax charge
148,630
247,185
The actual charge for the year can be reconciled to the expected charge for the year based on the profit or loss and the standard rate of tax as follows:
2025
2024
£
£
Profit before taxation
544,320
960,585
Expected tax charge based on the standard rate of corporation tax in the UK of 25.00% (2024: 25.00%)
136,080
240,146
Tax effect of expenses that are not deductible in determining taxable profit
38,533
33,755
Permanent capital allowances in excess of depreciation
(10,372)
(13,374)
Other non-reversing timing differences
(15,611)
(13,342)
Taxation charge
148,630
247,185
CARE IN MIND LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 23 -
8
Dividends
2025
2024
Recognised as distributions to equity holders:
£
£
Interim paid
334,494
341,659
9
Tangible fixed assets
Group
Plant and equipment
Fixtures and fittings
Computers
Motor vehicles
Total
£
£
£
£
£
Cost
At 1 April 2024
29,082
294,229
353,092
297,877
974,280
Additions
5,162
9,918
4,411
19,491
Disposals
(25,130)
(158,541)
(336,433)
(520,104)
At 31 March 2025
9,114
145,606
21,070
297,877
473,667
Depreciation and impairment
At 1 April 2024
25,647
203,351
335,427
122,533
686,958
Depreciation charged in the year
3,084
22,417
11,435
58,403
95,339
Eliminated in respect of disposals
(25,130)
(149,991)
(336,391)
(511,512)
At 31 March 2025
3,601
75,777
10,471
180,936
270,785
Carrying amount
At 31 March 2025
5,513
69,829
10,599
116,941
202,882
At 31 March 2024
3,435
90,878
17,665
175,344
287,322
CARE IN MIND LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
9
Tangible fixed assets
(Continued)
- 24 -
Company
Fixtures and fittings
Computers
Total
£
£
£
Cost
At 1 April 2024
12,450
262,134
274,584
Additions
4,411
4,411
Disposals
(5,848)
(245,950)
(251,798)
At 31 March 2025
6,602
20,595
27,197
Depreciation and impairment
At 1 April 2024
9,731
246,637
256,368
Depreciation charged in the year
1,011
9,446
10,457
Eliminated in respect of disposals
(5,848)
(245,950)
(251,798)
At 31 March 2025
4,894
10,133
15,027
Carrying amount
At 31 March 2025
1,708
10,462
12,170
At 31 March 2024
2,719
15,497
18,216
10
Fixed asset investments
Group
Company
2025
2024
2025
2024
Notes
£
£
£
£
Investments in subsidiaries
11
3
3
Movements in fixed asset investments
Company
Shares in subsidiaries
£
Cost or valuation
At 1 April 2024 and 31 March 2025
3
Carrying amount
At 31 March 2025
3
At 31 March 2024
3
11
Subsidiaries
Details of the company's subsidiaries at 31 March 2025 are as follows:
CARE IN MIND LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
11
Subsidiaries
(Continued)
- 25 -
Name of undertaking
Registered office
Class of
% Held
shares held
Direct
Care In Mind Residential Limited
Hope House Unit B Hercules Office Park, Bird Hall Lane, Stockport, Cheshire, United Kingdom, SK3 0UX
Ordinary
100.00
12
Financial instruments
Group
Company
2025
2024
2025
2024
£
£
£
£
Carrying amount of financial assets include:
Debt instruments measured at amortised cost
2,561,107
2,272,273
n/a
n/a
Carrying amount of financial liabilities include:
Measured at amortised cost
852,943
931,535
n/a
n/a
As permitted by the reduced disclosure framework within FRS 102, the company has taken advantage of the exemption from disclosing the carrying amount of certain classes of financial instruments, denoted by 'n/a' above.
13
Debtors
Group
Company
2025
2024
2025
2024
Amounts falling due within one year:
£
£
£
£
Trade debtors
866,272
766,369
3,069
Corporation tax recoverable
77,414
77,414
77,414
77,414
Amounts owed by group undertakings
-
-
-
26,619
Other debtors
1,674,344
1,505,904
881,477
749,052
Prepayments and accrued income
265,766
233,053
119,609
95,556
2,883,796
2,582,740
1,078,500
951,710
Amounts falling due after more than one year:
Deferred tax asset (note 18)
11,453
Total debtors
2,895,249
2,582,740
1,078,500
951,710
CARE IN MIND LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 26 -
14
Creditors: amounts falling due within one year
Group
Company
2025
2024
2025
2024
Notes
£
£
£
£
Bank loans
16
60,500
60,500
Obligations under finance leases
17
33,032
57,127
Trade creditors
213,694
184,015
114,127
90,360
Amounts owed to group undertakings
134,076
Corporation tax payable
220,821
260,432
Other taxation and social security
145,021
133,434
67,705
69,181
Other creditors
263,873
292,934
909
690
Accruals and deferred income
170,019
131,496
96,707
46,216
1,106,960
1,119,938
413,524
206,447
15
Creditors: amounts falling due after more than one year
Group
Company
2025
2024
2025
2024
Notes
£
£
£
£
Bank loans and overdrafts
16
110,812
171,417
Obligations under finance leases
17
1,013
34,046
111,825
205,463
-
-
16
Loans and overdrafts
Group
Company
2025
2024
2025
2024
£
£
£
£
Bank loans
171,312
231,917
Payable within one year
60,500
60,500
Payable after one year
110,812
171,417
The above loan is provided by HSBC plc. These loans are secured by way of legal charge against all assets including freehold and leasehold property. Further details of each charge can be obtained from Companies House.
The original value of the loan was £242,000, with a fixed interest rate of 9.9% per annum. It is repayable over 48 months and is expected to mature in January 2028.
CARE IN MIND LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 27 -
17
Finance lease obligations
Group
Company
2025
2024
2025
2024
£
£
£
£
Future minimum lease payments due under finance leases:
Within one year
33,032
57,127
In two to five years
1,013
34,046
34,045
91,173
-
-
Finance lease payments represent rentals payable by the company or group for certain items of plant and machinery. Leases include purchase options at the end of the lease period, and no restrictions are placed on the use of the assets. The average lease term is 3 years. All leases are on a fixed repayment basis and no arrangements have been entered into for contingent rental payments.
18
Deferred taxation
The following are the major deferred tax liabilities and assets recognised by the group and company, and movements thereon:
Liabilities
Liabilities
Assets
Assets
2025
2024
2025
2024
Group
£
£
£
£
Accelerated capital allowances
-
4,158
11,453
-
Liabilities
Liabilities
Assets
Assets
2025
2024
2025
2024
Company
£
£
£
£
Accelerated capital allowances
3,042
4,554
-
-
Group
Company
2025
2025
Movements in the year:
£
£
Liability at 1 April 2024
4,158
4,554
Credit to profit or loss
(15,611)
(1,512)
Liability/(Asset) at 31 March 2025
(11,453)
3,042
The deferred tax asset set out above is not expected to reverse within 12 months and relates to a deferred tax asset net of deferred tax liability. They relate to accelerated capital allowances that are not expected to mature within the same period.
CARE IN MIND LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 28 -
19
Retirement benefit schemes
2025
2024
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
292,163
226,283
A defined contribution pension scheme is operated for all qualifying employees. The assets of the scheme are held separately from those of the group in an independently administered fund.
20
Share capital
Group and company
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
200
200
200
200
21
Merger reserve
2025
2024
Group
£
£
At the beginning and end of the year
595,428
595,428
2025
2024
Company
£
£
At the beginning and end of the year
-
-
On 5 April 2018, Care in Mind Limited acquired 100% of the share capital of Care in Mind Residential Services Limited from a director. As the ultimate controlling party was the same before and after the transaction, the combination has been accounted for using merger accounting in accordance with FRS 102 Section 19. As a result the above other reserve has been generated.
22
Profit and loss reserves
Group
Company
2025
2024
2025
2024
£
£
£
£
At the beginning of the year
1,485,434
1,113,693
803,331
790,657
Profit for the year
395,690
713,400
239,407
354,333
Dividends
(334,494)
(341,659)
(334,494)
(341,659)
At the end of the year
1,546,630
1,485,434
708,244
803,331
CARE IN MIND LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 29 -
23
Operating lease commitments
Lessee
The operating leases represents leases of properties and printers from both third parties and related parties. Relate party commitments total £3,321,388 (2024: £1,407,364). The property leases are negotiated over terms of 4 to 10 years and rentals are subject to regular rent reviews. The printer leases are negotiated over terms of 5 years.
At the reporting end date the group had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:
Group
Company
2025
2024
2025
2024
£
£
£
£
Within one year
885,514
319,008
8,998
-
Between two and five years
2,585,604
943,356
50,932
-
In over five years
112,000
208,000
-
-
3,583,118
1,470,364
59,930
-
24
Events after the reporting date
On 17 October 2025 the Care In Mind Limited group underwent a restructure. See note note 27 for further detail.
25
Related party transactions
Transactions with related parties
At 31 March 2025 there was a debtor balance of £1,670,961 (2024: £1,478,637) owed by related parties.
During the year the Care in Mind Limited group made purchases from related parties of £816,912 (2024: £435,992).
26
Directors' transactions
Dividends totalling £334,494 (2024 - £341,659) were paid in the year in respect of shares held by the company's directors.
At 31 March 2025 there was a debtor balance of £137,078 (2024: £237,078) relating to Dr D M Kingsley. This loan is interest free.
During the year the company advanced £344,781 (2024: £358,962) to Dr D M Kingsley and repayments from the Director was £444,781(2024: £358,962).
27
Controlling party
At 31 March 2025, the ultimate controlling party of Care In Mind Limited was Dr David Kingsley by virtue of his 100% shareholding.
On 24 July 2025, Care In Mind Holdings Limited (CRN: 16605728) was incorporated and on 17 October 2025, Care In Mind Holdings Limited acquired 100% of the share capital of Care In Mind Limited. The ultimate controlling party of Care In Mind Holdings Limited is Dr David Kingsley by virtue of his 100% shareholding.
CARE IN MIND LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 30 -
28
Cash generated from group operations
2025
2024
£
£
Profit after taxation
395,690
713,400
Adjustments for:
Taxation charged
148,630
247,185
Finance costs
34,848
34,738
Investment income
(4,878)
(10,353)
Loss on disposal of tangible fixed assets
8,592
8,389
Depreciation and impairment of tangible fixed assets
95,339
120,582
Movements in working capital:
Increase in debtors
(401,056)
(595,729)
Increase/(decrease) in creditors
50,728
(222,256)
Cash generated from operations
327,893
295,956
29
Analysis of changes in net funds - group
1 April 2024
Cash flows
31 March 2025
£
£
£
Cash at bank and in hand
540,559
(277,647)
262,912
Borrowings excluding overdrafts
(231,917)
60,605
(171,312)
Obligations under finance leases
(91,173)
57,128
(34,045)
217,469
(159,914)
57,555
2025-03-312024-04-01falsefalseCCH SoftwareCCH Accounts Production 2025.300Dr D M KingsleyR E O'DriscollDr R E O'DriscollMr D J PowerMr A M Knightfalse06906017bus:Consolidated2024-04-012025-03-31069060172024-04-012025-03-3106906017bus:Director12024-04-012025-03-3106906017bus:Director32024-04-012025-03-3106906017bus:Director42024-04-012025-03-3106906017bus:Director52024-04-012025-03-3106906017bus:Director22024-04-012025-03-3106906017bus:RegisteredOffice2024-04-012025-03-31069060172025-03-3106906017bus:Consolidated2025-03-3106906017bus:Consolidated2023-04-012024-03-31069060172023-04-012024-03-3106906017bus:Consolidated2024-03-31069060172024-03-3106906017core:PlantMachinerybus:Consolidated2025-03-3106906017core:FurnitureFittingsbus:Consolidated2025-03-3106906017core:ComputerEquipmentbus:Consolidated2025-03-3106906017core:MotorVehiclesbus:Consolidated2025-03-3106906017core:PlantMachinerybus:Consolidated2024-03-3106906017core:FurnitureFittingsbus:Consolidated2024-03-3106906017core:ComputerEquipmentbus:Consolidated2024-03-3106906017core:MotorVehiclesbus:Consolidated2024-03-3106906017core:FurnitureFittings2025-03-3106906017core:ComputerEquipment2025-03-3106906017core:FurnitureFittings2024-03-3106906017core:ComputerEquipment2024-03-3106906017core:CurrentFinancialInstrumentscore:WithinOneYearbus:Consolidated2025-03-3106906017core:CurrentFinancialInstrumentsbus:Consolidated2024-03-3106906017core:ShareCapitalbus:Consolidated2025-03-3106906017core:ShareCapitalbus:Consolidated2024-03-3106906017core:OtherMiscellaneousReservebus:Consolidated2025-03-3106906017core:OtherMiscellaneousReservebus:Consolidated2024-03-3106906017core:RetainedEarningsAccumulatedLossesbus:Consolidated2025-03-3106906017core:RetainedEarningsAccumulatedLossesbus:Consolidated2024-03-3106906017core:ShareCapital2025-03-3106906017core:ShareCapital2024-03-3106906017core:RetainedEarningsAccumulatedLosses2025-03-3106906017core:RetainedEarningsAccumulatedLosses2024-03-3106906017core:ShareCapitalbus:Consolidated2023-03-31069060172023-03-3106906017core:ShareCapital2023-03-3106906017core:RetainedEarningsAccumulatedLosses2023-03-3106906017bus:Consolidated2023-03-3106906017core:PlantMachinery2024-04-012025-03-3106906017core:FurnitureFittings2024-04-012025-03-3106906017core:ComputerEquipment2024-04-012025-03-3106906017core:MotorVehicles2024-04-012025-03-3106906017core:UKTaxbus:Consolidated2024-04-012025-03-3106906017core:UKTaxbus:Consolidated2023-04-012024-03-3106906017core:PlantMachinerybus:Consolidated2024-03-3106906017core:FurnitureFittingsbus:Consolidated2024-03-3106906017core:ComputerEquipmentbus:Consolidated2024-03-3106906017core:MotorVehiclesbus:Consolidated2024-03-3106906017bus:Consolidated2024-03-3106906017core:FurnitureFittings2024-03-3106906017core:ComputerEquipment2024-03-31069060172024-03-3106906017core:PlantMachinerybus:Consolidated2024-04-012025-03-3106906017core:FurnitureFittingsbus:Consolidated2024-04-012025-03-3106906017core:ComputerEquipmentbus:Consolidated2024-04-012025-03-3106906017core:MotorVehiclesbus:Consolidated2024-04-012025-03-3106906017core:Subsidiary12024-04-012025-03-3106906017core:Subsidiary112024-04-012025-03-3106906017core:CurrentFinancialInstrumentsbus:Consolidated2025-03-3106906017core:CurrentFinancialInstruments2025-03-3106906017core:CurrentFinancialInstruments2024-03-3106906017core:CurrentFinancialInstrumentsbus:Consolidated12025-03-3106906017core:CurrentFinancialInstrumentsbus:Consolidated12024-03-3106906017core:CurrentFinancialInstruments22025-03-3106906017core:CurrentFinancialInstruments32025-03-3106906017core:Non-currentFinancialInstrumentsbus:Consolidated2025-03-3106906017core:Non-currentFinancialInstrumentsbus:Consolidated2024-03-3106906017core:Non-currentFinancialInstruments2025-03-3106906017core:Non-currentFinancialInstruments2024-03-3106906017core:WithinOneYearbus:Consolidated2025-03-3106906017core:WithinOneYearbus:Consolidated2024-03-3106906017core:CurrentFinancialInstrumentscore:WithinOneYear2025-03-3106906017core:CurrentFinancialInstrumentscore:WithinOneYear2024-03-3106906017core:Non-currentFinancialInstrumentscore:AfterOneYearbus:Consolidated2025-03-3106906017core:Non-currentFinancialInstrumentscore:AfterOneYearbus:Consolidated2024-03-3106906017core:Non-currentFinancialInstrumentscore:AfterOneYear2025-03-3106906017core:Non-currentFinancialInstrumentscore:AfterOneYear2024-03-3106906017core:CurrentFinancialInstrumentscore:WithinOneYearbus:Consolidated2024-03-3106906017core:WithinOneYear2025-03-3106906017core:WithinOneYear2024-03-3106906017core:BetweenTwoFiveYearsbus:Consolidated2025-03-3106906017core:BetweenTwoFiveYearsbus:Consolidated2024-03-3106906017core:BetweenTwoFiveYears2025-03-3106906017core:BetweenTwoFiveYears2024-03-3106906017bus:PrivateLimitedCompanyLtd2024-04-012025-03-3106906017bus:FRS1022024-04-012025-03-3106906017bus:Audited2024-04-012025-03-3106906017bus:ConsolidatedGroupCompanyAccounts2024-04-012025-03-3106906017bus:FullAccounts2024-04-012025-03-31xbrli:purexbrli:sharesiso4217:GBP